Enrollment is complete for a Phase 2 trial testing Zenas Biopharma's obexelimab in relapsing MS, with results expected later ...

Columnist Ben Hofmeister is able to tell when people want the short answer to questions about his health. Too bad most MS answers are long.

Columnist Desiree Lama has had to find some self-care strategies for managing her MS while also staying atop her work as a ...

Quantum signed a manufacturing agreement for the production of Lucid-MS as it prepares for a Phase 2 trial of the ...

Beneficiaries of plans that covered fewer than the median number of DMTs in the past year were more likely to have a relapse, ...